M

MedScout

Sales-focused revenue acceleration for medical devices

Enterprise Account Executive

Full-Time
$140k - $165k/yr+ Uncapped commissions + Accelerators + Bonuses for exceeding quota
Senior
Remote in USA
RemoteRemote-first role with in-person conferences and industry events, about 8–10 per year, plus team on-sites.
Sales & Account ManagementAccount Executive
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • Have a track record as a top performer.
  • Have at least 2 years of medical device sales experience, at least 2 years of enterprise software-as-a-service selling experience, and over 5 total years of selling experience.
  • Have sold deals with at least $100,000 in annual recurring revenue at an early-stage venture-capital-backed startup.
  • Have software sales experience primarily focused on new business hunting.
  • Have experience selling into large enterprise organizations and working with various stakeholders throughout the sales process.
  • Be comfortable selling in person and remotely, including in conference rooms, board rooms, and Zoom meetings.
  • Be able to engage with C-suite and vice president-level executives at target customers and understand their needs and priorities.
Responsibilities
  • Act as a go-to-market consultant to help prospects understand how to use the company's data, insights, and tools to empower their commercial teams.
  • Use industry knowledge to uncover and address the needs of sales, sales operations, and marketing teams at large medical device and diagnostics companies in the United States.
  • Collaborate daily with leadership, sales team members, and the marketing team on strategy, and represent potential customers' perspectives to product teams.
  • Advocate internally for product development that helps customers get their products to the people who need them.
  • Represent the company at conferences, industry events, and other in-person meetings, with approximately 8–10 events anticipated per year.
  • Own the sales process from start to finish and develop a deep pipeline of clients.

About the company

M

MedScout

View
Website

MedScout.io is a revenue acceleration platform for medical device and diagnostic companies. It helps sales teams by integrating CRM, maps, spreadsheets, and note apps in a single interface, streamlining the sales workflow. The platform uses medical claims intelligence from public and private payors to identify potential customers—physicians, medical centers, and other target accounts—based on each salesperson’s criteria. This enables territory expansion and discovery of new growth opportunities, especially for on-the-road reps. Revenue comes from subscription plans (monthly or annual), with a free trial and easy enrollment of whole sales teams. Unlike generic CRM add-ons, MedScout.io is purpose-built for the healthcare device market, combining data-driven targeting with seamless CRM integration to speed up selling cycles and keep teams aligned.

Company Size

51-200

Company Stage

Early VC

Total Funding

$30.8M

Headquarters

Austin, Texas

Founded

2021

Get referred to MedScout

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • On February 24, 2026, MedScout raised $10 million led by Fulcrum Equity Partners.
  • Enterprise revenue tripled since July 2024, signaling strong expansion within MedTech accounts.
  • August 27, 2026 leadership hires added Chris Edwards, Cassie Sixt, and Mark Isham.

What critics are saying

  • Definitive Healthcare, IQVIA, and Zymewire already crowd MedTech commercial intelligence.
  • MedScout's data advantage depends on payer and claims feeds that competitors can replicate.
  • If Strategies underdelivers, enterprise buyers replace MedScout with spreadsheets and CRM workflows.

What makes MedScout unique

  • MedScout turns claims data into territory plans for MedTech reps.
  • Strategies agents encode each customer's commercial playbook, not generic healthcare ontologies.
  • GE Healthcare uses MedScout, validating enterprise relevance in complex MedTech workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Vision Insurance
  • Dental Insurance
  • Remote Work Options
  • Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

5%

2 year growth

7%
Business News This Week
Oct 7th, 2026
MedScout Launches Scout AI and the MedScout MCP to Advance Commercial Intelligence for MedTech Teams.

MedScout Launches Scout AI and the MedScout MCP to Advance Commercial Intelligence for MedTech Teams. Scout AI builds target lists, briefs, outreach and routes inside MedScout, while the MedScout MCP brings that intelligence into Claude, Copilot, Gemini and ChatGPT. AUSTIN, Texas (October 7, 2026) - MedScout, the commercial engine for MedTech, today announced the launch of Scout AI, which turns data and insights into complex analyses, target lists, meeting briefs, physician outreach and daily routes reps can work the same day. Scout AI puts that intelligence to work inside MedScout, and the MedScout MCP brings it into Claude, Copilot, Gemini and ChatGPT. Scout AI takes manual, time-consuming tasks, like building target lists and prepping for meetings, and does the work in seconds. A rep can ask for the top providers in a given city on a given day, and Scout AI identifies the providers, determines where each is likely to be, and builds and optimizes a route in one step. Scout AI draws on MedScout's data covering procedure volume, referral patterns, payer mix, reimbursement, sites of care and industry payments to build the workflow. Teams can use Scout AI to: * Size a market before making a move, from deciding where the next rep should go to backfilling a role, with volume trends, payer mix, site of care, and reimbursement for one territory or two side by side. * Find best-fit providers that meet every targeting criterion at once, such as surgeons performing robotic procedures at hospitals but not at the system-affiliated ASCs, with no payments from a named competitor * Map referral networks and patient journeys to see who sends a provider their patients and where those patients go next * Build routes ordered around drive time and the days providers are actually on site. * Draft personalized outreach that providers are more likely to respond to, citing trends in their market, where referrals are going, and more. * Get pre-meeting briefs on a provider's procedures, patient population, affiliations and payer mix, framed around how to approach them. "For the past five years, we've worked hard to deeply understand our customers: their products, their teams, their strategies, and the impact they have on people's lives," said Skylar Talley, co-founder and CEO of MedScout. "MedScout.AI builds everything we've learned into software that actually does the work for commercial teams and delivers insights wherever they need them. I'm grateful to the more than 20 design partners who helped us build it. By this time next year, I believe our customers will think of Scout as a teammate, not a tool." The MedScout MCP connects MedScout to the AI platforms commercial teams already work in, including Claude, Copilot, Gemini, and ChatGPT. It is built for teams that want to combine MedScout's market data with their own CRM, ERP, billing or pricing data, such as finding high-volume providers who aren't in the CRM yet, or target accounts that haven't had a billing event. MedScout Strategies, code sets, territories and permissions carry through the connection, so teams get the same governed answers in either place. "With the MedScout MCP, our team pulls market insights right into Claude, where they accelerate quality outputs," said Matt Wallace, Vice President of Sales at Magnus Medical. "In the past month alone, we've cut hospital executive briefs from days to minutes, and we keep finding new use cases for MSA targeting and bespoke market analysis." Scout AI and the MedScout MCP run on the same claims-based intelligence, covering more than 330 million patient lives, more than 3.7 million healthcare providers and more than 700,000 sites of care. Scout AI is available today to MedScout customers in the MedScout web and mobile apps, with no setup required, and the MedScout MCP is available to all MedScout customers, with a two-week trial open to industry professionals. Both are part of a broader rebuild of the MedScout product suite around AI, with more to be announced later this year. To learn more or see Scout AI in action, visit medscout.io.

Smart Business News
Aug 27th, 2026
MedScout appoints new Chief Operating Officer, Vice President of Customer Success, and Vice President of Engineering.

MedScout appoints new Chief Operating Officer, Vice President of Customer Success, and Vice President of Engineering. Veteran leaders join MedScout to help MedTech companies turn AI ambition into revenue growth AUSTIN, Texas (August 27, 2026) - MedScout, the commercial engine for MedTech, today announced the appointment of Chris Edwards as Chief Operating Officer, Cassie Sixt as VP of Customer Success, and Mark Isham as Vice President of Engineering. In his new role, Edwards will lead MedScout's commercial strategy and operational execution, helping the company scale its go-to-market organization and expand the value it provides to MedTech sales and marketing teams. He will oversee the operating infrastructure that supports MedScout's continued growth, including revenue operations and commercialization. Before joining MedScout, Edwards spent more than ten years in consulting and technology, holding leadership roles at L.E.K. Consulting and Storable, where he ran a high-growth, multi-product SaaS business and rapidly scaled its commercial operations. "What drew me to MedScout was the long-term vision for the market," said Chris Edwards, Chief Operating Officer at MedScout. "Vendors in this market are trying to become the system of record, driving switching costs so high that customers end up stuck. MedTech teams don't need a forced, vendor-defined ontology of their business. They need to know where the opportunity is, and what to say next." Also joining the team is Cassie Sixt. As Vice President of Customer Success, Sixt will lead the expansion of the team that partners closely with customers to maximize value and outcomes. She brings extensive experience in customer success and client partnerships from leadership roles at Definitive Healthcare and Forrester. Stepping into a new role as MedScout's Vice President of Engineering is Marsh Isham. Isham is a seasoned engineering executive and startup founder with over 25 years of experience building enterprise-scale analytics platforms, most recently serving as SVP of Engineering at FullStory. "We couldn't be more excited to welcome Chris, Cassie, and Mark to the MedScout team," said Skylar Talley, CEO and Co-founder of MedScout. "AI is reshaping how MedTech teams sell, and their experience will be instrumental as we help organizations turn that shift into new business, faster."

HITshow
Mar 18th, 2026
MedScout raises $10M growth round, rolls out "Strategies" AI agents for MedTech sales teams.

MedScout raises $10M growth round, rolls out "Strategies" AI agents for MedTech sales teams. Fulcrum Equity Partners led the financing, with Live Oak Venture Partners and Stage 2 Capital participating; the company says it has tripled enterprise revenue since its July 2024 Series A. MedScout closed a $10 million growth funding round led by Fulcrum Equity Partners, with participation from existing investors Live Oak Venture Partners and Stage 2 Capital. The Austin-based company's round more than doubled its valuation compared with its prior Series A and will be used to continue investing in its AI product capabilities and to support demand from enterprise customers. Alongside the funding, MedScout announced the launch of "Strategies," a set of AI agents designed to translate commercial strategy into territory-level plans for field representatives. The company said the agents analyze inputs such as market and account-level referral networks, procedure volumes, and payer dynamics to generate prioritized target lists and recommended actions. MedScout framed the product around a common operational gap in MedTech sales: strategy is set centrally, while field teams often rely on a mix of search, spreadsheets, and data tools that do not provide guidance on what to do next. The company said each agent is configured to a customer's commercial approach and definition of target accounts, and that Strategies became available to customers in late 2025. The company also shared adoption and growth metrics it attributed to customer activity: MedScout said customers deployed 81% more unique AI agents in January than in the prior month, and that enterprise revenue has grown 3x since its July 2024 Series A. It also reported 135% month-over-month growth in monthly active reps as customers expanded usage.

MedScout
Feb 25th, 2026
MedScout

MedScout just closed a $10M growth round led by Fulcrum Equity Partners, with participation from existing investors Live Oak Venture Partners and Stage 2 Capital.

Meditation Affinity
Feb 25th, 2026
MedScout Raises $10M and Launches AI Agents for MedTech Commercial Teams

MedScout raises $10M and launches AI agents for MedTech commercial teams. Posted On February 25, 2026 Backed by Fulcrum Equity Partners, MedScout has grown enterprise revenue by 3x since its Series A as MedTech companies adopt AI agents to turn commercial strategy into field execution AUSTIN, TX - Feb 25 MedScout, the commercial engine for MedTech, announced a $10M growth round led by Fulcrum Equity Partners, with participation from existing investors Live Oak Venture Partners and Stage 2 Capital. The round, which more than doubled the company's valuation from its Series A, will fuel continued investment in MedScout's AI capabilities and support growing demand from enterprise customers. "MedScout is tackling one of the most pressing challenges in MedTech: turning company strategy into revenue performance," said Philip Lewis, Partner at Fulcrum Equity Partners. "What they've built combines commercial expertise and AI to solve that problem in a highly actionable way that's unique to each customer. This is the future of how companies put AI to work, and it's why we're doubling down on our investment in MedScout." Alongside the funding, MedScout is launching Strategies, AI agents that analyze market and account-level referral networks, procedure volumes, payer dynamics, and more to deliver prioritized, ready-to-work territory plans to reps. Discover more The Bhagavad Gita Shrimad Bhagavad Gita "MedTech companies spend months developing commercial strategies that don't make it to the field as intended," said Skylar Talley, Co-founder and CEO of MedScout. "MedScout bridges that gap by translating commercial priorities into clear, territory-specific actions. Sales reps know which providers to prioritize and how to build and expand those relationships." MedTech commercial teams face a core disconnect: strategy is set at the top, but the tools reps use in the field don't reflect it. Instead, reps rely on Google, stale spreadsheets, or data platforms that lack the context to tell them what really matters. Each Strategy is an AI agent built around a company's specific commercial context, how it wins in the market, and its definition of a best-fit target. Drawing on industry expertise and field-tested patterns from working with hundreds of MedTech commercial teams, each agent can pinpoint the accounts and physicians most likely to convert. MedScout made Strategies available to customers in late 2025. "In January, our customers deployed 81% more unique AI agents than the month before - evidence that sales teams are seeing value quickly and building on early success," said Talley. MedScout's growth reflects the urgency of the problem it solves. Enterprise MedTech organizations are increasingly relying on MedScout to keep their large and distributed sales forces focused on the right accounts and opportunities. Enterprise revenue has grown 3x since its Series A in July 2024, and monthly active reps are up 135% month over month as sales teams expand their use of Strategies. "Everything we do is in service of better patient outcomes, and that starts with getting our innovations into the hands of the right clinicians," said Meraj Khan, Chief Marketing Officer, Surgical Innovations at GE Healthcare. "MedScout has been a strategic partner in helping our field teams identify, prioritize, and connect with the facilities and providers where our technologies can have the greatest impact. The result is stronger commercial performance and more patients benefiting from precision care. We're proud to work with MedScout and excited for this next phase of our partnership." MedScout customers deploy Strategies aligned to their specific growth priorities and market positioning, such as: * A surgical robotics company pinpoints orthopedic surgeons who perform high volumes of traditional total knee replacements, have a Medicare-heavy patient mix (60%+), and haven't adopted robotic-assisted procedures. Reps get a clear list of high-fit targets where the clinical case for adoption is already established. * A diagnostic imaging company identifies primary care physicians within a 25-mile radius of a priority account who see patients with pulmonary nodules but refer lung biopsies to competing practices. Reps receive a prioritized list of physicians whose referral patterns offer the greatest opportunity to expand biopsy volume at the target facility. * A cardiology device company identifies hospitals that performed 30% fewer TAVR procedures year over year while maintaining 250+ annual cardiac catheterization cases. Reps get a ranked list of high-capacity programs losing structural heart volume - a clear signal to re-evaluate technology partnerships. Each site has a tailored ROI story that quantifies revenue at risk and frames a path to recapture volume. MedScout is actively deploying Strategies within commercial teams across MedTech.